Arlington, MA, United States of America

Mariangela Amenduni

USPTO Granted Patents = 8 

Average Co-Inventor Count = 16.3

ph-index = 3

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
8 patents (USPTO):

Title: The Innovative Journey of Mariangela Amenduni in Automated Cell Culture

Introduction

Mariangela Amenduni, an accomplished inventor based in Arlington, MA, has made significant contributions to the field of biotechnology. With a remarkable portfolio of seven patents, she has focused on developing advanced platforms and systems that enhance automated cell culture processes, marking her as a leader in her industry.

Latest Patents

Among her notable inventions, her latest patents include groundbreaking work on platforms and systems for automated cell culture. These innovations consist of a cell culture system that features a cell culture container capable of receiving input cells. The system incorporates a cell imaging subsystem that acquires images of the cell culture, a computing subsystem that executes cell culture processes based on these images, and a cell editing subsystem designed to modify the cell culture to produce desired output cell products.

Career Highlights

Mariangela currently works at Cellino Biotech, Inc., where she plays a pivotal role in advancing the company's innovative initiatives. Her dedication to the field of biotechnology and her expertise in cell culture technologies have positioned her as a critical figure in the company's mission to revolutionize cell-based therapies.

Collaborations

Throughout her career, Mariangela has collaborated with notable peers, including Matthias Wagner and Suvi Aivio. These partnerships have further enriched her work, enabling the development of more effective and innovative solutions for cell culture applications.

Conclusion

Mariangela Amenduni's dedication to innovation in automated cell culture has resulted in significant advancements within the biotechnology field. With her extensive patent portfolio and collaborative efforts, she continues to impact the industry positively, driving forward new technologies that will benefit research and therapeutic endeavors for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…